Inhibition of herpes simplex virus type 1 and adenovirus type 5 by heterocyclic Schiff bases of aminohydroxyguanidine tosylate
Authors:
- Melvin D TrousdaleMTMelvin D Trousdale
- Shijun RenSRShijun Ren
- Eric J LienELEric J Lien
- 1 December 1999
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 44 (3) , 201-208
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Activity of Ganciclovir Against Human Adenovirus Type-5 Infection in Cell Culture and Cotton Rat EyesCornea, 1994
- Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2′-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitroAntiviral Research, 1991
- Herpes and human ribonucleotide reductases: Inhibition by 2-acetylpyridine 5-[(2-chloroanilino)-thiocarbonyl]-thiocarbonohydrazone (348U87)Biochemical Pharmacology, 1991
- Design, synthesis, testing, and quantitative structure-activity relationship analysis of substituted salicylaldehyde Schiff bases of 1-amino-3-hydroxyguanidine tosylate as new antiviral agents against coronavirusJournal of Medicinal Chemistry, 1990
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Recombinant Human Interferon- Inhibits Adenovirus Multiplication in VitroJournal of General Virology, 1987
- Inhibition of ribonucleotide reductase and L1210 cell growth by N-hydroxy-N′-aminoguanidine derivativesBiochemical Pharmacology, 1985
- Optimization of the Schiff bases of N-hydroxy-N'-aminoguanidine as anticancer and antiviral agentsJournal of Medicinal Chemistry, 1985
- Novel N-hydroxyguanidine derivatives as anticancer and antiviral agentsJournal of Medicinal Chemistry, 1984
- Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VII. 2-Formylpyridine derivatives bearing additional ring substituentsJournal of Medicinal Chemistry, 1970